Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-03-27, Stock:PFE, The news for the past five days is as follows:
2020-03-20: NEWS1: Covid Report: How A Blockbuster Pfizer Drug Benefits From Coronavirus.NEWS2: Covid Report: How Pfizer Benefits; Plus, Malaria Drug Tested In Coronavirus.NEWS3: Pharma Stock Roundup: SNY, RHHBY, PFE's Coronavirus Product Development & Other Updates.NEWS4: 4 Dividend Stocks to Buy Amid the Coronavirus Rout.NEWS5: Dow falls nearly 150 points on losses in shares of Goldman Sachs, Exxon Mobil.NEWS6: Does ibuprofen make the coronavirus worse? Is it still safe to take aspirin?.NEWS7: Health Canada okays GSK unit's monthly HIV injection.NEWS8: Pfizer Stock Falls 3%.
2020-03-23: NEWS1: The Zacks Analyst Blog Highlights: Pfizer, Roche, Sanofi, Lilly and Merck.NEWS2: The Zacks Analyst Blog Highlights: Macy's, AbbVie, Pfizer and New Residential Investment.
2020-03-24: NEWS1: Peninsula biotech scores $80M upfront in potential $1.6 billion cancer drug deal.NEWS2: U.S. FDA Approves Supplemental New Drug Application (sNDA) for Expanded Indication of EUCRISA® (Crisaborole) Ointment, 2%, in Children as Young as 3 Months of Age With Mild-to-Moderate Atopic Dermatitis.
2020-03-25: NEWS1: Pfizer (PFE) Gains But Lags Market: What You Should Know.NEWS2: Pfizer pauses new studies due to coronavirus.NEWS3: Pfizer Inc. -- Moody's assigns A1 to Pfizer's notes, on review for downgrade.NEWS4: Pfizer's Eczema Drug Eucrisa Gets FDA Approval for Infants.NEWS5: Pfizer Is Entering The Coronavirus Drug Hunt — But Is PFE Stock A Buy?.NEWS6: Pfizer Stock Rises 3%.
2020-03-26: NEWS1: 5 Superstar Stocks on Sale During the Coronavirus Crisis.NEWS2: This portfolio manager draws on 2008 lessons to find stocks that will outlast a pandemic.NEWS3: Pfizer Stock Rises 5%.NEWS4: $110M injection powers up Peninsula vaccine maker — but not for COVID-19.NEWS5: The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizer's Upjohn-Mylan Merger.NEWS6: Mylan delays merger with Upjohn due to COVID-19 pandemic.NEWS7: Drugmakers Mylan, Pfizer delay merger due to coronavirus outbreak.NEWS8: Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn.

Answer: Decrease